Compare IQIYI Inc - ADR (IQ) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IQIYI Inc - ADR vs McKesson Corporation — how do they compare? IQIYI Inc - ADR trades at $1.34 (market cap $1.30B), while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 80.9× IQIYI Inc - ADR's market cap, and McKesson Corporation pays a 0.42% dividend while IQIYI Inc - ADR pays none. Which is the better fit depends on your goals.
| IQ | MCK | |
|---|---|---|
Market Cap | $1.30B | $105.14B |
Sector | Media | Health |
52-Week High | $2.79 | $995.69 |
52-Week Low | $0.96 | $659.01 |
Enterprise Value | $2.88B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
